D.E. Shaw & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.9M | Sell |
|
|||||
|
2025
Q2 | $61.3M | Buy |
|
|||||
|
2025
Q1 | $38.6M | Buy |
|
|||||
|
2024
Q4 | $18.1M | Buy |
|
|||||
|
2024
Q3 | $11.5M | Sell |
|
|||||
|
2024
Q2 | $22.1M | Sell |
|
|||||
|
2024
Q1 | $36.9M | Buy |
|
|||||
|
2023
Q4 | $18.6M | Sell |
|
|||||
|
2023
Q3 | $46.4M | Sell |
|
|||||
|
2023
Q2 | $78.9M | Sell |
|
|||||
|
2023
Q1 | $110M | Sell |
|
|||||
|
2022
Q4 | $146M | Buy |
|
|||||
|
2022
Q3 | $86.4M | Sell |
|
|||||
|
2022
Q2 | $86.9M | Buy |
|
|||||
|
2022
Q1 | $53.1M | Sell |
|
|||||
|
2021
Q4 | $81.4M | Buy |
|
|||||
|
2021
Q3 | $59.9M | Buy |
|
|||||
|
2021
Q2 | $43.5M | Sell |
|
|||||
|
2021
Q1 | $43.7M | Sell |
|
|||||
|
2020
Q4 | $51.6M | Buy |
|
|||||
|
2020
Q3 | $4.67M | Buy |
|
|||||
|
2020
Q2 | $558K | Sell |
|
|||||
|
2020
Q1 | $8.24M | Sell |
|
|||||
|
2019
Q4 | $23.3M | Buy |
|
|||||
|
2019
Q3 | $9.64M | Buy |
|
|||||
|
2019
Q2 | $7.4M | Sell |
|
|||||
|
2019
Q1 | $9.97M | Sell |
|
|||||
|
2018
Q4 | $20.1M | Buy |
|
|||||
|
2018
Q3 | $9.52M | Buy |
|
|||||
|
2018
Q2 | $1.57M | Sell |
|
|||||
|
2018
Q1 | $6.95M | Sell |
|
|||||
|
2017
Q4 | $14.6M | Buy |
|
|||||
|
2017
Q3 | $8.54M | Buy |
|
|||||
|
2017
Q2 | $1.33M | Buy |
|
|||||
|
2017
Q1 | $263K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $8.03M | Sell |
|
|||||
|
2016
Q2 | $10.4M | Sell |
|
|||||
|
2016
Q1 | $18.8M | Sell |
|
|||||
|
2015
Q4 | $41.7M | Sell |
|
|||||
|
2015
Q3 | $48.2M | Sell |
|
|||||
|
2015
Q2 | $87.8M | Buy |
|
|||||
|
2015
Q1 | $56.6M | Buy |
|
|||||
|
2014
Q4 | $14.6M | Sell |
|
|||||
|
2014
Q3 | $18.1M | Buy |
|
|||||
|
2014
Q2 | $7.21M | Buy |
|
|||||
|
2014
Q1 | $637K | Sell |
|
|||||
|
2013
Q4 | $1.73M | Sell |
|
|||||
|
2013
Q3 | $42.6M | Sell |
|
|||||
|
2013
Q2 | $60.2M | Buy |
|